National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Maryland 20892, United States.
Bioconjug Chem. 2011 Jun 15;22(6):1001-5. doi: 10.1021/bc200005w. Epub 2011 May 24.
Herein, we report a new type of in vivo fluorogenic probe that enables simultaneous and active targeting of overexpressed receptors, α(V)β(3) integrins, and extracellular proteases, matrix metalloproteinases (MMPs), in the tumor regions. This c(RGDyK)-conjugated MMP fluorogenic probe efficiently targets the tumor regions with high retention time while maintaining receptor binding affinity and substrate activity. The probe minimizes nonspecific accumulation, thus demonstrating improved tumor-to-background signal ratio (T/N) in both α(V)β(3) integrin- and MMP-overexpressing U87MG tumor-bearing mouse model. This strategy can be easily tuned for a wide array of applications targeting various receptors and extracellular proteases in vivo.
在此,我们报告了一种新型的活体荧光探针,它能够同时主动靶向过表达的受体、α(V)β(3)整合素和细胞外蛋白酶、基质金属蛋白酶(MMPs)在肿瘤区域。这种 c(RGDyK)-缀合的 MMP 荧光探针能够高效地靶向肿瘤区域,同时保持受体结合亲和力和底物活性。该探针最大限度地减少了非特异性积累,因此在 α(V)β(3)整合素和 MMP 过表达的 U87MG 荷瘤小鼠模型中,提高了肿瘤与背景信号的比值(T/N)。这种策略可以很容易地针对各种受体和细胞外蛋白酶在体内的广泛应用进行调整。